Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Differential diagnosis of multiple sclerosis in children].
Khabirov FA, Khaybullin TI, Granatov EV, Averyanova LA, Babicheva NN, Khaibullina AR, Shikhova VA, Yakupov MA. Khabirov FA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(7. Vyp. 2):60-67. doi: 10.17116/jnevro202212207260. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35912558 Russian.
[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].
Boyko AN, Lashch NY, Sharanova SN, Zakharova MN, Trifonova OV, Simaniv TO, Lysogorskaya EV, Guryanova OE, Kotov SV, Iakushina TI, Lizhdvoy VY, Belova YA, Khabirov FA, Babicheva NN, Khaibullin TI, Granatov EV, Averyanova LA, Sazonov DV, Odinak MM, Trinitatsky YV, Tsukurova LA, Sergeeva AI, Ivanov RA, Shustova MS. Boyko AN, et al. Among authors: khabirov fa. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10 Pt 2):61-67. doi: 10.17116/jnevro201611610261-67. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28139613 Clinical Trial. Russian.
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko PV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Lin'kova YN, Zinkina-Orikhan AV, Tursunova KB. Boyko AN, et al. Among authors: khabirov fa. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):107-113. doi: 10.17116/jnevro201711722107-113. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617368 Clinical Trial. Russian.
Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.
Ivanova VV, Khaiboullina SF, Gomzikova MO, Martynova EV, Ferreira AM, Garanina EE, Sakhapov DI, Lomakin YA, Khaibullin TI, Granatov EV, Khabirov FA, Rizvanov AA, Gabibov A, Belogurov A Jr. Ivanova VV, et al. Among authors: khabirov fa. Front Immunol. 2017 Oct 16;8:1335. doi: 10.3389/fimmu.2017.01335. eCollection 2017. Front Immunol. 2017. PMID: 29085375 Free PMC article.
49 results